NCT05140655View on ClinicalTrials.gov

Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-

UnknownOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

April 19, 2022

Study Completion Date

August 19, 2022

Conditions
Breast Neoplasm Female
Interventions
DRUG

Fulvestrant

Medicine for Advanced breast cancer

Trial Locations (1)

Unknown

RECRUITING

SOHEC, Valledupar

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories SAS

INDUSTRY